BRIDGEWATER, N.J., Nov. 8, 2023
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases, today announced that
management will present at the following investor conferences:
- The Stifel 2023 Healthcare Conference in New York on Tuesday,
November 14, 2023, at 8:00 a.m.
ET in a fireside chat
- The 6th Annual Evercore ISI HealthCONx Conference in
Miami on Wednesday, November 29, 2023, at 11:15 a.m. ET in a fireside chat
Each fireside chat will be webcast live and can be accessed by
visiting the investor relations section of the Company's website
at www.insmed.com. Each webcast will be archived for a
period of 30 days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases. Insmed's
first commercial product is a first-in-disease therapy
approved in the United States,
Europe, and Japan to treat a chronic, debilitating lung
disease. The Company is progressing a robust pipeline of
investigational therapies targeting areas of serious unmet need,
including neutrophil-mediated inflammatory diseases and rare
pulmonary disorders. Insmed is also advancing an
early-stage research engine encompassing a wide range of
technologies and modalities, including artificial
intelligence-driven protein engineering, gene therapy, and protein
manufacturing. Insmed is headquartered in
Bridgewater, New Jersey, with additional offices and
research locations throughout the United
States, Europe, and
Japan. Visit www.insmed.com
to learn more.
Contact:
Investors:
Bryan Dunn
Executive Director, Investor
Relations
Insmed
(646)
812-4030
bryan.dunn@insmed.com
Eleanor Barisser
Associate Director, Investor
Relations
Insmed
(718)
594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate
Communications
Insmed
(732)
718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-two-november-conferences-301980947.html
SOURCE Insmed Incorporated